One Bio
PrivateLast Round
Series A
Dec 12, 2024
Total Funding Raised
$44.12M
Company Overview
One Bio operates in Healthcare & Life Sciences and is based in Davis, California. Its latest recorded funding round was a Series A round in December 2024.
One Bio is a biotechnology company that develops naturally-derived oligosaccharides from plant fibers designed for food, agriculture, and biopharmaceutical applications to support microbiome health and immune function.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
One Bio Comparables
Compare One Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Brightseed | 84% | |
| Carbiotix | 77% | |
| BIOHM Health | 74% |
For institutional investors. Book with your work email.
One Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 12, 2024 | ||||
| Series A | Apr 13, 2022 | ||||
| Grant | Dec 1, 2021 | ||||
| Seed | Nov 1, 2020 | ||||
| Grant | Oct 21, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
One Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Morado Ventures | Series A |
| Better Ventures | Series A |
| iSelect Fund | Series A, Seed |
| Skyviews Life Science | Series A |
| Gates Foundation | Grant |
| Acre Venture Partners | Series A |
| Collaborative Fund | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 12, 2024
$27M round led by Alpha Edison.
- Apr 13, 2022
$12M round led by Acre Venture Partners.
For institutional investors. Book with your work email.
One Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about One Bio's valuation, stock price, and market status.
Is One Bio a public or private company?
One Bio is a private company.
What is the current stock price of One Bio?
One Bio is a private company, so its shares have no public market price. Caplight tracks One Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is One Bio worth (valuation)?
Valuation information for One Bio is not publicly available.
Can I buy One Bio stock?
One Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was One Bio's last funding round?
One Bio's most recent funding round was Series A on December 12, 2024.
Who are the main investors in One Bio?
Key investors in One Bio include Acre Venture Partners, Alpha Edison.
Will One Bio IPO soon?
No public IPO plans have been announced for One Bio.
How can I track One Bio secondary market activity?
Caplight tracks bids, offers, and trades in One Bio's shares on secondary markets.